WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New ATC

Overview of new ATC codes decided at the two previous meeting of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the ATC codes from the latest meeting (temporary codes) should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new ATC will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.

ATC codeATC level name (INN/generic name)Deadline for objection to temporary code 1) Implementation in the ATC/DDD index
A02BC07dexrabeprazoleFinal2015
A02BC53lansoprazole, combinationsFinal2015
A02BC54rabeprazole, combinationsFinal2015
A02BD09lansoprazole, clarithromycin and tinidazoleFinal2015
A02BD10lansoprazole, amoxicillin and levofloxacinFinal2015
A03AX14valethamateFinal2015
A03CA09pipenzolate and psycholepticsFinal2015
A03FA07itroprideFinal2015
A04AA55palonosetron, combinationsFinal2015
A10BD16metformin and canagliflozinFinal2015
A10BD17metformin and acarboseFinal2015
A10BD18metformin and gemigliptin01.09.20142015
A10BD19linagliptin and empagliflozin01.09.20142015
A10BX13albiglutideFinal2015
A16AB12elosulfase alfaFinal2015
B01AC25cangrelorFinal2015
B01AC26vorapaxar01.09.20142015
B02BD13coagulation factor XFinal2015
B02BD14susoctocog alfa01.09.20142015
C02KX05riociguatFinal2015
C05AE03diltiazemFinal2015
C07FB12nebivolol and other hypertensivesFinal2015
C09CA10fimasartan01.09.20142015
C09DA09azilsartan medoxomil and diureticsFinal2015
C10AX13evolocumab01.09.20142015
C10BX06atorvastatin, acetylsalicylic acid and ramiprilFinal2015
C10BX07rosuvastatin, amlodipine and lisinoprilFinal2015
C10BX08atorvastatin and acetylsalicylic acidFinal2015
C10BX09rosuvastatin and amlodipineFinal2015
D03AX12trolamineFinal2015
D04AA16pheniramineFinal2015
D07XC05fluocortoloneFinal2015
D08AJ10decamethoxine01.09.20142015
D10AF05nadifloxacinFinal2015
D10AF06sulfacetamideFinal2015
D11AX22ivermectin01.09.20142015
G01AF19sertaconazoleFinal2015
G01AX16hexetidineFinal2015
G03XB51mifepristone, combinations01.09.20142015
G04BE10avanafilFinal2015
G04BE11udenafilFinal2015
J01DD51cefotaxime, combinationsFinal2015
J01RA06cefepime and amikacin Final2015
J01RA07azithromycin, fluconazole and secnidazole Final2015
J01RA08tetracycline and oleandomycin Final2015
J01RA09ofloxacin and ornidazole Final2015
J01RA10ciprofloxacin and metronidazole Final2015
J01RA11ciprofloxacin and tinidazole Final2015
J01RA12ciprofloxacin and ornidazoleFinal2015
J01RA13norfloxacin and tinidazoleFinal2015
J01XE03furazidinFinal2015
J01XE51nitrofurantoin, combinationsFinal2015
J04AK07amithiozoneFinal2015
J05AE13faldaprevirFinal2015
J05AE14simeprevirFinal2015
J05AE15asunaprevir01.09.20142015
J05AR12lamivudine and tenofovir disoproxil Final2015
J05AR13 lamivudine, abacavir and dolutegravirFinal2015
J05AR14darunavir and cobicistatFinal2015
J05AX13umifenovir Final2015
J05AX14daclatasvir01.09.20142015
J05AX15sofosbuvir01.09.20142015
J06BB18raxibacumabFinal2015
L01BC59trifluridine, combinations01.09.20142015
L01XC16dinutuximabFinal2015
L01XE26cabozantinibFinal2015
L01XE27ibrutinibFinal2015
L01XE28ceritinib01.09.20142015
L01XX46olaparibFinal2015
L01XX47idelalisibFinal2015
L02BB04enzalutamide Final2015
L03AA15balugrastimFinal2015
L03AB13peginterferon beta-1aFinal2015
L03AB14cepeginterferon alfa-2bFinal2015
L03AX19dasiprotimut-T01.09.20142015
L04AA33vedolizumab Final2015
L04AC11siltuximab01.09.20142015
M02AA27dexketoprofenFinal2015
M03BX55thiocolchicoside, combinationsFinal2015
M05BB07risedronic acid and colecalciferolFinal2015
M09AB03bromelainsFinal2015
N05AX15cariprazineFinal2015
N05BX04fabomotizole01.09.20142015
N06DA53donepezil, memantine and Ginkgo foliumFinal2015
N06DX30combinationsFinal2015
P01AB51metronidazole, combinationsFinal2015
R01AA15indanazolineFinal2015
R03AL05formoterol and aclidinium bromide Final2015
R03BA09fluticasone furoate01.09.20142015
R03BB07umeclidinium bromideFinal2015
R03BB54tiotropium bromide, combinationsFinal2015
R03DC53montelukast, combinationsFinal2015
R06AA10trimethobenzamideFinal2015
S01CC02indometacin and antiinfectivesFinal2015
S01EC54brinzolamide, combinationsFinal2015
S01FA54cyclopentolate, combinationsFinal2015
V04CD06macimorelin01.09.20142015
V08DA06perflubutane polymer microspheresFinal2015
V09AX06florbetaben (18F) Final2015
1) Final: indicates that the date for objection has expired

Last updated: 2014-05-09